I am way behind on Trading Account updates. I actually haven’t made any trades in it, so in addition to being behind on updates I have also neglected it. I decided yesterday to close out my remaining two positions and begin paying closer attention to it.
The two positions I had were Bank of America (BAC) and Pfizer (PFE). I opened the positions in 201, BAC in August and PFE in April. Both of the positions were designed to be held longer-term with the focus on long-term appreciation. At the time, I believed both companies were undervalued. Of the big banks I thought BAC had the most room to run up. Over the 1.5 years since it was purchased it rose from $6.90 to $12.13.
Pfizer, in my opinion, was also undervalued. I thought the focus was too much on the negativity of losing patents on drugs. The company earns money and pays a good dividend. At the time, I had expected it to reach $25 within a year. Almost two years later it is at $28.26.
Below you can see the trades and the profit of each.